Pembrolizumab in Advanced Gastrointestinal Malignancies with Defective DNA Mismatch Repair: A Case Series

Pembrolizumab in Advanced Gastrointestinal Malignancies with Defective DNA Mismatch Repair: A Case Series

Background: Tumors with deficient mismatch repair (dMMR) have a favorable immunological phenotype permitting exploitation by immunotherapies. We aimed to assess our institutional experience of dMMR advanced gastrointestinal (GI) cancers treated with the PD-1 inhibitor pembrolizumab. Materials and Me...

Full description

Bibliographic Details
Main Authors:	David D Stenehjem, Courtney C Cavalieri, Eric Swanson, Benjamin Solomon, Jonathan Whisenant, Dao Tran, John Weis, G Weldon Gilcrease, Sunil Sharma, Ignacio Garrido-Laguna
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2018-07-01
Series:	Journal of Immunotherapy and Precision Oncology
Subjects:	case series defective dna mismatch repair gastrointestinal malignancies immunotherapy pembrolizumab
Online Access:	https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_5_1

Similar Items

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study
by: Giuseppe Lombardi, et al.
Published: (2020-08-01)

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
by: Michael M. Boyiadzis, et al.
Published: (2018-05-01)

Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma
by: Joy M. Davis, et al.
Published: (2024-06-01)

Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Cancer
by: Tan Chongqing, et al.
Published: (2021-12-01)

Real-world efficacy and safety of low-dose pembrolizumab in patients with advanced and refractory gynecologic cancers
by: Chien-Hsiang Kao, et al.
Published: (2024-04-01)

Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities
by: Alessandro Rizzo
Published: (2022-07-01)

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
by: Ryosuke Oki, et al.
Published: (2023-01-01)

Microsatellite Instability and Metastatic Colorectal Cancer – A Clinical Perspective
by: Tomas Buchler
Published: (2022-04-01)

Expression of programmed cell death ligand-1 and mismatch repair status in endometrial carcinomas
by: Madhubala Rajendran, et al.
Published: (2023-01-01)

A rapid, simple DNA mismatch repair substrate construction method
by: Timothy James Kinsella, et al.
Published: (2011-06-01)

Mismatch Repair Deficiency and Microsatellite Instability
by: Sandra Schöniger, et al.
Published: (2022-08-01)

Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry
by: Federica Zito Marino, et al.
Published: (2022-04-01)

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series
by: Maja L. Nádorvári, et al.
Published: (2024-02-01)

Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD)
by: N. C. Ramchander, et al.
Published: (2017-04-01)

Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era
by: Keitaro Shimozaki, et al.
Published: (2023-03-01)

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
by: Aoife J McCarthy, et al.
Published: (2019-04-01)

Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series
by: Peter G. Rose, et al.
Published: (2023-12-01)

DNA Mismatch Repair Assessment in Gastric and Colon Cancers Using Stochastic Microdisks
by: Prof. Dr. Raluca‐Ioana Stefan‐van Staden, et al.
Published: (2023-11-01)

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)
by: Matthew Gumbleton, et al.
Published: (2023-02-01)

Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus <italic toggle="yes">Cryptococcus neoformans</italic>
by: Kylie J. Boyce, et al.
Published: (2017-07-01)

Association of clinicopathological features with DNA mismatch repair status among colorectal cancer patients presenting to a Tertiary Care Cancer Hospital
by: Gayathri G Nair, et al.
Published: (2022-01-01)

A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy
by: Rebecca Lin, et al.
Published: (2024-02-01)

Effect of mismatch repair genes expression in right colon cancer on pathological characteristics
by: YAN Wanneng, MA Haijie, SHEN Chaomin
Published: (2021-01-01)

Bronchiolitis Obliterans after Combination Immunotherapy with Pembrolizumab and Ipilimumab
by: Amulya Balagani, et al.
Published: (2018-07-01)

Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report
by: Israa Mahmood, PharmD, et al.
Published: (2021-01-01)

Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review
by: Tulika Chatterjee, et al.
Published: (2022-01-01)

Evaluation of mismatch-repair and microsatellite-instability status in a Chinese colorectal cancer Cohort
by: Peng Zhang, et al.
Published: (2024-02-01)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
by: Marta Mendiola, et al.
Published: (2023-09-01)

Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
by: Elham Sajjadi, et al.
Published: (2021-05-01)

The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer
by: Bangwei Fang, et al.
Published: (2023-01-01)

Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability
by: Madhura Deshpande, et al.
Published: (2020-11-01)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
by: Shou-Sheng Liu, et al.
Published: (2018-07-01)

Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients
by: Min Jin, et al.
Published: (2022-10-01)

Sporadic colorectal polyps and mismatch repair proteins
by: Mahsa Molaei, et al.
Published: (2011-01-01)

Constitutional Mismatch Repair Deficiency Syndrome in a patient from India
by: Chandramallika Paul, et al.
Published: (2020-12-01)

Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
by: Xin-yu Ren, et al.
Published: (2021-03-01)

Alleviation of C⋅C Mismatches in DNA by the Escherichia coli Fpg Protein
by: Almaz Nigatu Tesfahun, et al.
Published: (2021-06-01)

Mismatched, but Not Aware of It? How Subjective and Objective Skill Mismatch Affects Employee Job Satisfaction
by: Stephan Bischof
Published: (2021-10-01)

The Startling Role of Mismatch Repair in Trinucleotide Repeat Expansions
by: Guy-Franck Richard
Published: (2021-04-01)

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report
by: Dennis Hoch, et al.
Published: (2023-11-01)